研究单位:[1]Tongji Hospital, Huazhong University of Science and Technology,Wuhan,Hubei,China[2]Huangshi Central Hospital, China[3]Xiaogan Central Hospital[4]Ezhou Central Hospital[5]Jingzhou Central Hospital
We plan to evaluate the efficacy and safety of cetuximab combined with anti-PD-1 and mFOLFOX6 in the treatment of RAS/BRAF WT locally advanced or metastatic right colon cancer